Literature DB >> 17134415

Idebenone: a new antioxidant - Part I. Relative assessment of oxidative stress protection capacity compared to commonly known antioxidants.

D H McDaniel1, B A Neudecker, J C DiNardo, J A Lewis, H I Maibach.   

Abstract

Topical applications of skin care products containing antioxidants have become increasingly popular. Numerous studies have elucidated the biological effects of these substances. General antiaging effects, anti-inflammatory properties, photoprotective properties, and prevention of ultraviolet (UV) immunosuppression have been documented. However, a standardized method to characterize and compare the properties and oxidative stress protection capacity of antioxidants was lacking. A multistep in vitro process utilizing a variety of biochemical and cell biological methods combined with in vivo studies was designed to compare the oxidative stress protective capacity of commonly used antioxidants. Data were presented for L-ascorbic acid, dl-alpha-tocopherol, kinetin, dl-alpha lipoic acid, ubiquinone, and idebenone. Methods included using UV-induced radical trapping/scavenging capacity measured by photochemiluminescence, pro-oxidative systems (LDL-CuSO(4), microsome-NADPH/ADP/Fe(3+)) with measurement of primary and secondary oxidation products, UVB irradiation of human keratinocytes, and in vivo evaluation, using the human sunburn cell (SBC) assay. Correlation and trends between in vitro and in vivo results were established, and the standardized test protocol was used to quantify oxidative stress protection capacity of antioxidants. Summarizing and totaling the data equally weighted for each oxidative stress study, the overall oxidative protection capacity scores of 95, 80, 68, 55, 52, and 41 were obtained for idebenone, dl-alpha tocopherol, kinetin, ubiquinone, L-ascorbic acid, and dl-alpha lipoic acid, respectively. The higher the score, the more effective the overall oxidative stress protection capacity of the antioxidant became. This multistep protocol may serve as a standard in investigating and comparing new putative antioxidants for topical use as well as a valuable tool to assess the anti-inflammatory properties, photoprotective properties, and prevention of UV immunosuppression of topical antioxidants.

Entities:  

Year:  2005        PMID: 17134415     DOI: 10.1111/j.1473-2165.2005.00152.x

Source DB:  PubMed          Journal:  J Cosmet Dermatol        ISSN: 1473-2130            Impact factor:   2.696


  8 in total

1.  Nanostructured lipid carriers improve skin permeation and chemical stability of idebenone.

Authors:  Bei Li; Zhi-Qiang Ge
Journal:  AAPS PharmSciTech       Date:  2012-01-11       Impact factor: 3.246

Review 2.  Pharmacotherapy for Friedreich ataxia.

Authors:  Amy Y Tsou; Lisa S Friedman; Robert B Wilson; David R Lynch
Journal:  CNS Drugs       Date:  2009       Impact factor: 5.749

3.  Use of Noben (idebenone) in the treatment of dementia and memory impairments without dementia.

Authors:  K V Voronkova; M N Meleshkov
Journal:  Neurosci Behav Physiol       Date:  2009-06

4.  A new minimally invasive mesotherapy technique for facial rejuvenation.

Authors:  Antonella Savoia; Simone Landi; Alfonso Baldi
Journal:  Dermatol Ther (Heidelb)       Date:  2013-01-08

Review 5.  Cytokinins: Wide-Spread Signaling Hormones from Plants to Humans with High Medical Potential.

Authors:  Moustafa Fathy; Sahar M Saad Eldin; Muhammad Naseem; Thomas Dandekar; Eman M Othman
Journal:  Nutrients       Date:  2022-04-02       Impact factor: 5.717

Review 6.  Impact on facial rejuvenation with dermatological preparations.

Authors:  Patrick J Bowler
Journal:  Clin Interv Aging       Date:  2009-05-14       Impact factor: 4.458

Review 7.  Cutaneous Photoprotection: A Review of the Current Status and Evolving Strategies.

Authors:  Kathleen Suozzi; Jack Turban; Michael Girardi
Journal:  Yale J Biol Med       Date:  2020-03-27

8.  Facile Solvent-Free Preparation of Antioxidant Idebenone-Loaded Nanoparticles for Efficient Wound Healing.

Authors:  HeeSeon Yang; Sohyeon Yu; Jisu Kim; KumJu Baek; Young-Ran Lee; Hye Sun Lee; Won Il Choi; Daekyung Sung
Journal:  Pharmaceutics       Date:  2022-02-26       Impact factor: 6.321

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.